Pattern of Uncomplicated Malaria Treatment and Antimalarial Prescription Practices among Health Workers in the Littoral Region of Cameroon: An Assessment of Ten Years Post-Malaria Treatment Policy Change
- 1 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 2 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 3 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 4 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 5 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 6 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 7 National Roll Back Malaria Committee, Yaoundé, Cameroon
Abstract
Following highly prevalent Plasmodium resistant strains to antimalarial monotherapies in malaria endemic countries, uncomplicated malaria treatment policy changed to artemisinine-based combination therapies (ACTs). After adoption of this new treatment policy in a country, sufficient care is needed to be taken to prevent occurrence of resistance to the latest drugs. As Cameroon shifted to ACT in 2004, this study aimed to assess knowledge and practices of health workers in government health facilities of the Littoral region regarding mild malaria management in health facilities as well as according to prescription qualities of ACTs in leaflets received in pharmacies. A total of 66 physicians and 16 nurses were questioned in 10 health facilities and 503 medical leaflets with ACTs prescriptions were viewed in 17 pharmacies. All medical workers questioned correctly were defined mild malaria and were aware of the antimalarial policy change in Cameroon. Overall ACTs prescription for mild malaria management in children and adult patients was 72.2% and 87.8% respectively. An important proportion of health workers prescribed antimalarial monotherapies and non recommended antimalarial for uncomplicated malaria treatment. 31.7% of participants did not systematically recommend laboratory diagnostic test before antimalarial prescription. Of leaflets viewed in pharmacies, ACTs were prescribed by physicians, nurses and laboratory technicians. Age was the only criteria for ACTs prescription. Appropriate ACTs quality prescription ranged between 81.2% and 94.4%. Of the ACTs prescribed, blisters had the highest (92.9%) appropriate quality prescription and solutions the lowest (83.3%). According to qualification of prescribers, physicians had the highest score (93.1%) of appropriate quality prescription and laboratory technicians the lowest score (28.1%). For all ACTs containing medical leaflets, concomitant medications were recorded namely antipyretic (73.9%), antibiotic (21.9%), non steroid anti-inflammatory (19.9%) or vitamins (18.1%). Data gathered indicated that although health workers were aware of uncomplicated malaria treatment policy change in Cameroon, mild malaria mismanagement was prevailing in health facilities of the Littoral region and ACTs quality prescription in medical leaflets was not optimal. Therefore, awareness is still needed among prescribers in order to prevent or at least slow the occurrence of Plasmodium resistant strains to ACTs in Cameroon.
- World Health Organization (2014) The World Malaria Report 2014. World Health Organization, Geneva, WHO/HTM/ GMP/2014, 242 p.
- World Health Organization (2013) The World Malaria Report 2013. World Health Organization, Geneva, WHO/HTM/ GMP/2013, 286 p.
- Flegg, J.A., Metcalf, C.J.E., Gharbi, M., Venkatesan, M., et al. (2013) Trends in Antimalarial Drug Use in Africa. The American Journal of Tropical Medicine and Hygiene, 89, 857-865. http://dx.doi.org/10.4269/ajtmh.13-0129
- Packard, R.M. (2014) The Origins of Antimalarial-Drug Resistance. The New England Journal of Medicine, 371, 397-399. http://dx.doi.org/10.1056/NEJMp1403340
- D'Alessandro, U. and Buttiëns, H. (2001) History and Importance of Antimalarial Drug Resistance. Tropical Medicine & International Health, 6, 845-848. http://dx.doi.org/10.1046/j.1365-3156.2001.00819.x
- World Health Organization (2001) Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation. WHO/CDS/RBM, 35.
- Sinclair, D., Zani, B., Donegan, S., Olliaro, P. and Garner, P. (2009) Artemisinine-Based Combination Therapy for Treating Uncomplicated Malaria (Review). Cochrane Reviews, 4, 270 p.
- Adjuik, M., Agnamey, P., Babiker, A., Borrmann, S., Brasseur, P., et al. (2002) Amodiaquine-Artesunate versus Amodiaquine for Uncomplicated Plasmodium falciparum Malaria in African Children: A Randomised, Multicentre Trial. Lancet, 359, 1365-1372. http://dx.doi.org/10.1016/S0140-6736(02)08348-4
- Mutabingwa, T.K., Heller, A., Hallett, R., Ahmed, J., et al. (2005) Amodiaquine Alone, Amodiaquine/Sulfadox-ine-Pyrimethamine, Amodiaquine/Artesunate, and Artemether/Lumefantrine for Outpatient Treatment of Malaria in Tanzanian Children: A Four-Arm-Randomised Effectiveness Trial. Lancet, 365, 1474-1480. http://dx.doi.org/10.1016/S0140-6736(05)66417-3
- Ogbonna, A. and Uneke, C.J. (2008) Artemisinin-Based Combination Therapy for Uncomplicated Malaria in Sub-Saharan Africa: The Efficacy, Safety, Resistance and Policy Implementation since Abuja 2000. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102, 621-627. http://dx.doi.org/10.1016/j.trstmh.2008.03.024
- Massougbodji, A., Kone, M., Kinde-Gazar, D., Same-Ekobo, A., et al. (2002) Randomised, Doubled-Blind Study on the Efficacy and Safety of Artesunate and Mefloquine (Artequin®) Given Simultaneously for 3 Days Compared to a Sequential Treatment in Uncomplicated Plasmodium falciparum Malaria in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 655-659. http://dx.doi.org/10.1016/S0035-9203(02)90344-5